Serveur d'exploration Chloroquine

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.

Identifieur interne : 000C58 ( Main/Exploration ); précédent : 000C57; suivant : 000C59

A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.

Auteurs : David R. Cameron [États-Unis] ; Yue Shan [États-Unis] ; Eliza A. Zalis [États-Unis] ; Vincent Isabella [États-Unis] ; Kim Lewis [États-Unis]

Source :

RBID : pubmed:29941425

Descripteurs français

English descriptors

Abstract

Persisters represent a small subpopulation of cells within a bacterial culture that are tolerant to killing by antibiotics. Persisters have been linked to recalcitrant infections caused by numerous bacterial pathogens, including Pseudomonas aeruginosa A classic example is the incurable infection of the airways for patients with cystic fibrosis. The genetic mediators of persister formation for P. aeruginosa are poorly understood. We generated a high-density transposon insertion library of P. aeruginosa PAO1 and determined the relative frequency of each insertion following fluoroquinolone treatment using transposon sequencing (Tn-seq). Of the 4,411 disrupted genes included in the screen, 137 had a ≥10-fold impact on survival. The gene disruption that resulted in the lowest survival rate was disruption of carB, which codes for the large subunit of carbamoyl phosphate synthetase (CPSase). CPSase is a metabolic enzyme that is involved in pyrimidine and arginine synthesis. Disruption of carB resulted in survival rates that were reduced by up to 2,500-fold following antibiotic treatment, and this phenotype was abolished by the addition of uracil, highlighting the importance of de novo pyrimidine biosynthesis for persister formation. Disruption of carB resulted in intracellular ATP accumulation, and lowering ATP levels using arsenate restored the antibiotic tolerance profile of the mutant to levels similar to those seen with the wild type. A decrease in ATP would lead to reduced antibiotic target activity and increased survival.IMPORTANCE Antibiotic treatment of P. aeruginosa residing in the lung of cystic fibrosis patients is ineffective. Treatment failure is attributed in part to antibiotic-tolerant phenotypic variants known as persister cells. Understanding how these cells emerge will likely inform future therapeutic strategies. In the current study, we identified carB, which codes for the large subunit of carbamoyl-phosphate synthetase, as a persister gene that contributes to multidrug tolerance in P. aeruginosa Disruption of carB resulted in a metabolic perturbation that increased cellular ATP and reduced persister formation. Conversely, lowering ATP in the mutant restored antibiotic tolerance. Our data support the hypothesis that a drop in intracellular ATP is a general mechanism of persister formation in bacteria.

DOI: 10.1128/JB.00303-18
PubMed: 29941425


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.</title>
<author>
<name sortKey="Cameron, David R" sort="Cameron, David R" uniqKey="Cameron D" first="David R" last="Cameron">David R. Cameron</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shan, Yue" sort="Shan, Yue" uniqKey="Shan Y" first="Yue" last="Shan">Yue Shan</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zalis, Eliza A" sort="Zalis, Eliza A" uniqKey="Zalis E" first="Eliza A" last="Zalis">Eliza A. Zalis</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Isabella, Vincent" sort="Isabella, Vincent" uniqKey="Isabella V" first="Vincent" last="Isabella">Vincent Isabella</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lewis, Kim" sort="Lewis, Kim" uniqKey="Lewis K" first="Kim" last="Lewis">Kim Lewis</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA k.lewis@northeastern.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2018">2018</date>
<idno type="RBID">pubmed:29941425</idno>
<idno type="pmid">29941425</idno>
<idno type="doi">10.1128/JB.00303-18</idno>
<idno type="wicri:Area/PubMed/Corpus">000101</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000101</idno>
<idno type="wicri:Area/PubMed/Curation">000101</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000101</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000131</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000131</idno>
<idno type="wicri:Area/Ncbi/Merge">000452</idno>
<idno type="wicri:Area/Ncbi/Curation">000452</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000452</idno>
<idno type="wicri:Area/Main/Merge">000C58</idno>
<idno type="wicri:Area/Main/Curation">000C58</idno>
<idno type="wicri:Area/Main/Exploration">000C58</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.</title>
<author>
<name sortKey="Cameron, David R" sort="Cameron, David R" uniqKey="Cameron D" first="David R" last="Cameron">David R. Cameron</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Shan, Yue" sort="Shan, Yue" uniqKey="Shan Y" first="Yue" last="Shan">Yue Shan</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Zalis, Eliza A" sort="Zalis, Eliza A" uniqKey="Zalis E" first="Eliza A" last="Zalis">Eliza A. Zalis</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Isabella, Vincent" sort="Isabella, Vincent" uniqKey="Isabella V" first="Vincent" last="Isabella">Vincent Isabella</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Lewis, Kim" sort="Lewis, Kim" uniqKey="Lewis K" first="Kim" last="Lewis">Kim Lewis</name>
<affiliation wicri:level="2">
<nlm:affiliation>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts, USA k.lewis@northeastern.edu.</nlm:affiliation>
<country wicri:rule="url">États-Unis</country>
<wicri:regionArea>Antimicrobial Discovery Center, Department of Biology, Northeastern University, Boston, Massachusetts</wicri:regionArea>
<placeName>
<region type="state">Massachusetts</region>
</placeName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Journal of bacteriology</title>
<idno type="eISSN">1098-5530</idno>
<imprint>
<date when="2018" type="published">2018</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adenosine Triphosphate (metabolism)</term>
<term>Anti-Bacterial Agents (pharmacology)</term>
<term>Biofilms (drug effects)</term>
<term>Carbon-Nitrogen Ligases (genetics)</term>
<term>Chloroquine (analogs & derivatives)</term>
<term>Chloroquine (pharmacology)</term>
<term>DNA Transposable Elements (genetics)</term>
<term>Drug Resistance, Multiple, Bacterial (genetics)</term>
<term>Escherichia coli (drug effects)</term>
<term>Escherichia coli (genetics)</term>
<term>High-Throughput Nucleotide Sequencing</term>
<term>Microbial Sensitivity Tests</term>
<term>Mutagenesis, Insertional</term>
<term>Pseudomonas aeruginosa (drug effects)</term>
<term>Pseudomonas aeruginosa (genetics)</term>
<term>Pseudomonas aeruginosa (pathogenicity)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adénosine triphosphate (métabolisme)</term>
<term>Antibactériens (pharmacologie)</term>
<term>Biofilms ()</term>
<term>Carbon-nitrogen ligases (génétique)</term>
<term>Chloroquine (analogues et dérivés)</term>
<term>Chloroquine (pharmacologie)</term>
<term>Escherichia coli ()</term>
<term>Escherichia coli (génétique)</term>
<term>Multirésistance bactérienne aux médicaments (génétique)</term>
<term>Mutagenèse par insertion</term>
<term>Pseudomonas aeruginosa ()</term>
<term>Pseudomonas aeruginosa (génétique)</term>
<term>Pseudomonas aeruginosa (pathogénicité)</term>
<term>Séquençage nucléotidique à haut débit</term>
<term>Tests de sensibilité microbienne</term>
<term>Éléments transposables d'ADN (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analogs & derivatives" xml:lang="en">
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Carbon-Nitrogen Ligases</term>
<term>DNA Transposable Elements</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Adenosine Triphosphate</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Anti-Bacterial Agents</term>
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="analogues et dérivés" xml:lang="fr">
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Biofilms</term>
<term>Escherichia coli</term>
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Drug Resistance, Multiple, Bacterial</term>
<term>Escherichia coli</term>
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Carbon-nitrogen ligases</term>
<term>Escherichia coli</term>
<term>Multirésistance bactérienne aux médicaments</term>
<term>Pseudomonas aeruginosa</term>
<term>Éléments transposables d'ADN</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Adénosine triphosphate</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en">
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr">
<term>Pseudomonas aeruginosa</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Antibactériens</term>
<term>Chloroquine</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>High-Throughput Nucleotide Sequencing</term>
<term>Microbial Sensitivity Tests</term>
<term>Mutagenesis, Insertional</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Biofilms</term>
<term>Escherichia coli</term>
<term>Mutagenèse par insertion</term>
<term>Pseudomonas aeruginosa</term>
<term>Séquençage nucléotidique à haut débit</term>
<term>Tests de sensibilité microbienne</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Persisters represent a small subpopulation of cells within a bacterial culture that are tolerant to killing by antibiotics. Persisters have been linked to recalcitrant infections caused by numerous bacterial pathogens, including
<i>Pseudomonas aeruginosa</i>
A classic example is the incurable infection of the airways for patients with cystic fibrosis. The genetic mediators of persister formation for
<i>P. aeruginosa</i>
are poorly understood. We generated a high-density transposon insertion library of
<i>P. aeruginosa</i>
PAO1 and determined the relative frequency of each insertion following fluoroquinolone treatment using transposon sequencing (Tn-seq). Of the 4,411 disrupted genes included in the screen, 137 had a ≥10-fold impact on survival. The gene disruption that resulted in the lowest survival rate was disruption of
<i>carB</i>
, which codes for the large subunit of carbamoyl phosphate synthetase (CPSase). CPSase is a metabolic enzyme that is involved in pyrimidine and arginine synthesis. Disruption of
<i>carB</i>
resulted in survival rates that were reduced by up to 2,500-fold following antibiotic treatment, and this phenotype was abolished by the addition of uracil, highlighting the importance of
<i>de novo</i>
pyrimidine biosynthesis for persister formation. Disruption of
<i>carB</i>
resulted in intracellular ATP accumulation, and lowering ATP levels using arsenate restored the antibiotic tolerance profile of the mutant to levels similar to those seen with the wild type. A decrease in ATP would lead to reduced antibiotic target activity and increased survival.
<b>IMPORTANCE</b>
Antibiotic treatment of
<i>P. aeruginosa</i>
residing in the lung of cystic fibrosis patients is ineffective. Treatment failure is attributed in part to antibiotic-tolerant phenotypic variants known as persister cells. Understanding how these cells emerge will likely inform future therapeutic strategies. In the current study, we identified
<i>carB</i>
, which codes for the large subunit of carbamoyl-phosphate synthetase, as a persister gene that contributes to multidrug tolerance in
<i>P. aeruginosa</i>
Disruption of
<i>carB</i>
resulted in a metabolic perturbation that increased cellular ATP and reduced persister formation. Conversely, lowering ATP in the mutant restored antibiotic tolerance. Our data support the hypothesis that a drop in intracellular ATP is a general mechanism of persister formation in bacteria.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Massachusetts</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Massachusetts">
<name sortKey="Cameron, David R" sort="Cameron, David R" uniqKey="Cameron D" first="David R" last="Cameron">David R. Cameron</name>
</region>
<name sortKey="Isabella, Vincent" sort="Isabella, Vincent" uniqKey="Isabella V" first="Vincent" last="Isabella">Vincent Isabella</name>
<name sortKey="Lewis, Kim" sort="Lewis, Kim" uniqKey="Lewis K" first="Kim" last="Lewis">Kim Lewis</name>
<name sortKey="Shan, Yue" sort="Shan, Yue" uniqKey="Shan Y" first="Yue" last="Shan">Yue Shan</name>
<name sortKey="Zalis, Eliza A" sort="Zalis, Eliza A" uniqKey="Zalis E" first="Eliza A" last="Zalis">Eliza A. Zalis</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000C58 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000C58 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    ChloroquineV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:29941425
   |texte=   A Genetic Determinant of Persister Cell Formation in Bacterial Pathogens.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:29941425" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a ChloroquineV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Wed Mar 25 22:43:59 2020. Site generation: Sun Jan 31 12:44:45 2021